Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-assisted therapy for severe alcohol use disorder
2022-002369-14Phase 2Active
- Sponsor
- CHU Brugmann
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in alcohol use disorder (AUD) comparing High-dose psilocybin + supportive psychotherapy with Active placebo + supportive psychotherapy (2 arms). Primary endpoint: Change in percentage of heavy drinking days. Started Dec 2022; status: active.
02
Drugs
psilocybin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2022-002369-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002369-14.